The Impact of ABO Blood Grouping on COVID-19 Vulnerability and Seriousness: A Retrospective Cross-Sectional Controlled Study among the Arab Community
Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. S...
Saved in:
Published in | International journal of environmental research and public health Vol. 18; no. 1; p. 276 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
01.01.2021
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 1660-4601 1661-7827 1660-4601 |
DOI | 10.3390/ijerph18010276 |
Cover
Abstract | Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. Subjects and Methods: This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, n = 726), and the other for the healthy people (Control group, n = 707). Results: The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection (p < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90–100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70–80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. Conclusion: The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups. |
---|---|
AbstractList | Background and Objectives:
Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients.
Subjects and Methods:
This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group,
n
= 726), and the other for the healthy people (Control group,
n
= 707).
Results:
The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection (
p
< 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90–100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70–80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover.
Conclusion:
The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups. Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. Subjects and Methods: This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, n = 726), and the other for the healthy people (Control group, n = 707). Results: The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection (p < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90–100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70–80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. Conclusion: The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups. Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. Subjects and Methods: This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, n = 726), and the other for the healthy people (Control group, n = 707). Results: The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection (p < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90-100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70-80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. Conclusion: The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups.Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. Subjects and Methods: This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, n = 726), and the other for the healthy people (Control group, n = 707). Results: The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection (p < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90-100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70-80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. Conclusion: The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups. Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, = 726), and the other for the healthy people (Control group, = 707). The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection ( < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90-100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70-80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover. The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups. |
Author | Alahmadi, Ahlam A. Almukadi, Haifa S. Arab, Rana A. Al-Sulami, Khayria A. El-Shitany, Nagla A. El-Hamamsy, Manal Faddladdeen, Khadija A. Badr-Eldin, Shaimaa M. Harakeh, Steve Eid, Basma G. Ali, Soad S. Bahshwan, Safia M. Neamatallah, Thikryat |
AuthorAffiliation | 10 Special Infectious Agents Unit, King Fahd Medical Research Center, Yousef Abdullatif Jameel Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia; sharakeh@gmail.com 1 Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; beid@kau.edu.sa (B.G.E.); Taneamatallah@kau.edu.sa (T.N.); hsalmukadi@kau.edu.sa (H.S.A.) 6 Medicine Program, Ibn Sina National Faculty for Medical Studies, Jeddah 22421, Saudi Arabia; charmingpearl1996@hotmail.com 3 Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; melhamamsy@kau.edu.sa 4 Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt 8 Department of Biology, Faculty of Science, Al-Baha University, Al-Baha 65511, Saudi Arabia; Safia_bahshw |
AuthorAffiliation_xml | – name: 8 Department of Biology, Faculty of Science, Al-Baha University, Al-Baha 65511, Saudi Arabia; Safia_bahshwan@yahoo.com – name: 11 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Sbadr5@hotmail.com – name: 4 Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt – name: 7 Department of Biology, Faculty of Science and Arts in Al-Makhwah, Al-Baha University, Al-Baha 65511, Saudi Arabia; Alsulamikhayria@gmail.com – name: 12 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt – name: 5 Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia; aahmadi1000@hotmail.com (A.A.A.); kfaddladdeen@kau.edu.sa (K.A.F.) – name: 1 Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; beid@kau.edu.sa (B.G.E.); Taneamatallah@kau.edu.sa (T.N.); hsalmukadi@kau.edu.sa (H.S.A.) – name: 3 Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; melhamamsy@kau.edu.sa – name: 10 Special Infectious Agents Unit, King Fahd Medical Research Center, Yousef Abdullatif Jameel Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia; sharakeh@gmail.com – name: 6 Medicine Program, Ibn Sina National Faculty for Medical Studies, Jeddah 22421, Saudi Arabia; charmingpearl1996@hotmail.com – name: 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt – name: 9 Department of Histology, Faculty of Medicine, Assiut University, Assiut 71515, Egypt; soadshaker@gmail.com |
Author_xml | – sequence: 1 givenname: Nagla A. orcidid: 0000-0003-2593-6879 surname: El-Shitany fullname: El-Shitany, Nagla A. – sequence: 2 givenname: Manal orcidid: 0000-0001-8822-5391 surname: El-Hamamsy fullname: El-Hamamsy, Manal – sequence: 3 givenname: Ahlam A. surname: Alahmadi fullname: Alahmadi, Ahlam A. – sequence: 4 givenname: Basma G. surname: Eid fullname: Eid, Basma G. – sequence: 5 givenname: Thikryat orcidid: 0000-0002-2762-7108 surname: Neamatallah fullname: Neamatallah, Thikryat – sequence: 6 givenname: Haifa S. surname: Almukadi fullname: Almukadi, Haifa S. – sequence: 7 givenname: Rana A. surname: Arab fullname: Arab, Rana A. – sequence: 8 givenname: Khadija A. surname: Faddladdeen fullname: Faddladdeen, Khadija A. – sequence: 9 givenname: Khayria A. surname: Al-Sulami fullname: Al-Sulami, Khayria A. – sequence: 10 givenname: Safia M. surname: Bahshwan fullname: Bahshwan, Safia M. – sequence: 11 givenname: Soad S. surname: Ali fullname: Ali, Soad S. – sequence: 12 givenname: Steve surname: Harakeh fullname: Harakeh, Steve – sequence: 13 givenname: Shaimaa M. surname: Badr-Eldin fullname: Badr-Eldin, Shaimaa M. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33401440$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Ustq3DAUFSUlr2bbZRF0041TydLIdheFidumA4GBJM1WyPJ1RoMsOZIdyIf0fyuTSUkCWemK89Dh6B6hPecdIPSRklPGKvLVbCEMG1oSSvJCvEOHVAiScUHo3rP5AB3FuCWElVxU--iAMU4o5-QQ_b3eAF71g9Ij9h1enq3xmfW-xefBT4Nxt9g7XK9vVj8yWuGbyToIqjHWjA9YuRZfQTB-ig5i_IaX-BLG4OMAejT3gOs0x-xqvnmnLK69S7C1kHTj1CaH3qcXxhRhmVwT3veTS9Yf0PtO2Qgnu_MY_fn187r-nV2sz1f18iLTnJZjRjsgVdnSQpCcC6YE0CLPO6EF1yzXtOug1VrppuRtw7qyIEwVgpdtIRrR8oodo--PvsPU9IkLKZ-ycgimV-FBemXkS8SZjbz197IoqgWnLBl82RkEfzdBHGVvogZrlYNUi8x5sVgwmpciUT-_om79FFItOxYVnM6JPj1P9D_K048lAn8k6LncAJ3UZlRzwSmgsZISOS-GfLkYSXb6Svbk_IbgHywsvO8 |
CitedBy_id | crossref_primary_10_35516_jjps_v17i2_1978 crossref_primary_10_1002_hsr2_1498 crossref_primary_10_1002_rmv_2247 crossref_primary_10_2147_JMDH_S330958 crossref_primary_10_25259_JHAS_26_2023 crossref_primary_10_1007_s00709_022_01754_1 crossref_primary_10_1002_bies_202100158 crossref_primary_10_1016_j_tracli_2022_10_003 crossref_primary_10_1016_j_micpath_2022_105658 crossref_primary_10_4103_amit_amit_57_23 crossref_primary_10_1016_j_transci_2021_103321 |
Cites_doi | 10.1016/j.meegid.2020.104485 10.1007/s00277-020-04348-0 10.1182/bloodadvances.2020002657 10.1038/s41467-020-19623-x 10.1016/j.nmni.2020.100763 10.30699/ijp.2020.125135.2367 10.1016/j.thromres.2020.04.013 10.1007/s00277-020-04169-1 10.1111/all.14238 10.1182/bloodadvances.2020002623 10.1128/CMR.00109-14 10.3389/fmed.2020.00491 10.1101/2020.07.17.20155986 10.1371/journal.pgen.1002480 10.3906/sag-2005-395 10.1177/0300060520949039 10.1161/ATVBAHA.119.313658 10.1111/vox.12786 10.1016/j.tracli.2020.08.009 10.3389/fcimb.2020.00404 10.1001/jama.2020.1585 10.1056/NEJMoa2001017 10.1021/acsnano.0c02624 10.1186/s43042-020-00097-x 10.1101/2020.04.15.20063107 10.1016/S0140-6736(20)30211-7 10.3201/eid2609.201932 10.1182/blood-2010-01-261859 10.3324/haematol.2020.266593 10.1093/glycob/cwn093 10.1056/NEJMoa2020283 10.1016/j.cytogfr.2020.05.009 10.1101/2020.01.31.929042 10.22541/au.160349176.67670206/v1 10.1128/JVI.00127-20 10.1101/2020.01.30.927806 10.1016/j.mehy.2020.110155 10.1111/vox.13004 10.3324/haematol.2020.265066 10.1101/2020.03.11.20031096 10.1136/gutjnl-2020-320926 10.1038/nature02145 10.1016/S0140-6736(20)30566-3 10.1056/NEJMoa2002032 10.3201/eid2607.200885 10.1111/bjh.16797 10.1111/irv.12758 10.1002/jmv.25725 10.1101/2020.06.13.20130211 10.1016/S0140-6736(20)30183-5 |
ContentType | Journal Article |
Copyright | 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 by the authors. 2021 |
Copyright_xml | – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 by the authors. 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM |
DOI | 10.3390/ijerph18010276 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1660-4601 |
ExternalDocumentID | PMC7795413 33401440 10_3390_ijerph18010276 |
Genre | Journal Article |
GeographicLocations | Saudi Arabia |
GeographicLocations_xml | – name: Saudi Arabia |
GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 7XC 88E 8C1 8FE 8FG 8FH 8FI 8FJ 8R4 8R5 A8Z AADQD AAFWJ AAHBH AAYXX ABGAM ABUWG ACGFO ACGOD ACIWK ADBBV AENEX AFKRA AFRAH AFZYC AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 DIK DU5 E3Z EBD EBS EJD EMB EMOBN F5P FYUFA GX1 HH5 HMCUK HYE KQ8 L6V M1P M48 MODMG O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO Q2X RNS RPM SV3 TR2 UKHRP XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PUEGO 7X8 ESTFP 5PM |
ID | FETCH-LOGICAL-c418t-1fe098d17602463a6e1722f6c64c32c1ffedccacb84db3f8703a7648d76b6d493 |
IEDL.DBID | M48 |
ISSN | 1660-4601 1661-7827 |
IngestDate | Thu Aug 21 13:43:11 EDT 2025 Fri Sep 05 09:27:19 EDT 2025 Tue Sep 02 07:40:58 EDT 2025 Mon Jul 21 05:57:23 EDT 2025 Tue Jul 01 04:30:32 EDT 2025 Thu Apr 24 23:09:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | COVID-19 blood group artificial respiration oxygen saturation myalgia |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c418t-1fe098d17602463a6e1722f6c64c32c1ffedccacb84db3f8703a7648d76b6d493 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-2593-6879 0000-0001-8822-5391 0000-0002-2762-7108 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijerph18010276 |
PMID | 33401440 |
PQID | 2475516419 |
PQPubID | 54923 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7795413 proquest_miscellaneous_2475531286 proquest_journals_2475516419 pubmed_primary_33401440 crossref_citationtrail_10_3390_ijerph18010276 crossref_primary_10_3390_ijerph18010276 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-01-01 20210101 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | International journal of environmental research and public health |
PublicationTitleAlternate | Int J Environ Res Public Health |
PublicationYear | 2021 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Flegel (ref_17) 2020; 105 Guo (ref_4) 2020; 26 ref_13 Anstee (ref_9) 2010; 115 Chen (ref_46) 2020; 395 ref_52 Wu (ref_14) 2020; 84 ref_19 Xia (ref_51) 2020; 92 ref_16 Ray (ref_20) 2020; 24 Fan (ref_25) 2020; 10 Barnkob (ref_27) 2020; 4 Malik (ref_2) 2020; 42 Wang (ref_45) 2020; 323 Jin (ref_53) 2020; 69 Ellinghaus (ref_15) 2020; 383 Taha (ref_30) 2020; 38 Latz (ref_35) 2020; 99 ref_22 Cooling (ref_36) 2015; 28 Gupta (ref_54) 2020; 90 Padhi (ref_29) 2020; 27 Guillon (ref_37) 2008; 18 Klok (ref_44) 2020; 191 Udugama (ref_8) 2020; 14 ref_26 Zietz (ref_33) 2020; 11 Huang (ref_48) 2020; 395 Lian (ref_47) 2020; 14 Oliveira (ref_10) 2020; 144 Groot (ref_11) 2020; 40 ref_34 ref_32 Zhan (ref_50) 2020; 48 Zhu (ref_5) 2020; 382 ref_39 Abdollahi (ref_31) 2020; 15 Hoiland (ref_21) 2020; 4 Gubernatorova (ref_42) 2020; 53 Zhou (ref_6) 2020; 395 Ayaz (ref_23) 2020; 50 Allami (ref_28) 2020; 21 Wan (ref_40) 2020; 94 Zhang (ref_1) 2020; 75 Li (ref_38) 2003; 426 ref_43 Du (ref_3) 2020; 26 Feng (ref_7) 2020; 7 ref_41 Li (ref_24) 2020; 190 Boudin (ref_18) 2020; 105 Stowell (ref_12) 2019; 114 ref_49 |
References_xml | – volume: 84 start-page: 104485 year: 2020 ident: ref_14 article-title: Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2020.104485 – ident: ref_26 doi: 10.1007/s00277-020-04348-0 – volume: 4 start-page: 4990 year: 2020 ident: ref_27 article-title: Reduced prevalence of SARS-CoV-2 infection in ABO blood group O publication-title: Blood Adv. doi: 10.1182/bloodadvances.2020002657 – volume: 11 start-page: 5761 year: 2020 ident: ref_33 article-title: Associations between blood type and COVID-19 infection, intubation, and death publication-title: Nat. Commun. doi: 10.1038/s41467-020-19623-x – volume: 38 start-page: 100763 year: 2020 ident: ref_30 article-title: Individuals with a Rh-positive but not Rh-negative blood group are more vulnerable to SARS-CoV-2 infection: Demographics and trend study on COVID-19 cases in Sudan publication-title: New Microbes New Infect. doi: 10.1016/j.nmni.2020.100763 – ident: ref_16 – volume: 90 start-page: 193 year: 2020 ident: ref_54 article-title: Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India publication-title: Monaldi Arch. Chest Dis. – volume: 24 start-page: m20-4511 year: 2020 ident: ref_20 article-title: Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness publication-title: Ann. Intern. Med. – volume: 15 start-page: 156 year: 2020 ident: ref_31 article-title: The novel coronavirus sars-cov-2 vulnerability association with abo/rh blood types publication-title: Iran. J. Pathol. doi: 10.30699/ijp.2020.125135.2367 – volume: 191 start-page: 145 year: 2020 ident: ref_44 article-title: Incidence of thrombotic complications in critically ill ICU patients with COVID-19 publication-title: Thromb. Res. doi: 10.1016/j.thromres.2020.04.013 – volume: 99 start-page: 2113 year: 2020 ident: ref_35 article-title: Blood type and outcomes in patients with COVID-19 publication-title: Ann. Hematol. doi: 10.1007/s00277-020-04169-1 – volume: 75 start-page: 1730 year: 2020 ident: ref_1 article-title: Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China publication-title: Allergy Eur. J. Allergy Clin. Immunol. doi: 10.1111/all.14238 – volume: 4 start-page: 4981 year: 2020 ident: ref_21 article-title: The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 publication-title: Blood Adv. doi: 10.1182/bloodadvances.2020002623 – volume: 42 start-page: 3 year: 2020 ident: ref_2 article-title: Properties of Coronavirus and SARS-CoV-2—PubMed publication-title: Malays. J. Pathol. – volume: 28 start-page: 801 year: 2015 ident: ref_36 article-title: Blood groups in infection and host susceptibility publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.00109-14 – volume: 7 start-page: 491 year: 2020 ident: ref_7 article-title: Clinical Characteristics and Short-Term Outcomes of Severe Patients with COVID-19 in Wuhan, China publication-title: Front. Med. doi: 10.3389/fmed.2020.00491 – ident: ref_32 doi: 10.1101/2020.07.17.20155986 – ident: ref_41 doi: 10.1371/journal.pgen.1002480 – volume: 50 start-page: 679 year: 2020 ident: ref_23 article-title: The effects of blood group types on the risk of COVID-19 infection and its clinical outcome publication-title: Turk. J. Med. Sci. doi: 10.3906/sag-2005-395 – volume: 48 start-page: 1 year: 2020 ident: ref_50 article-title: Retrospective analysis of clinical characteristics of 405 patients with COVID-19 publication-title: J. Int. Med. Res. doi: 10.1177/0300060520949039 – volume: 40 start-page: 830 year: 2020 ident: ref_11 article-title: Genetically determined ABO blood group and its associations with health and disease publication-title: Arter. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.119.313658 – volume: 114 start-page: 535 year: 2019 ident: ref_12 article-title: Biologic roles of the ABH and Lewis histo-blood group antigens part II: Thrombosis, cardiovascular disease and metabolism publication-title: Vox Sang. doi: 10.1111/vox.12786 – volume: 27 start-page: 253 year: 2020 ident: ref_29 article-title: ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population publication-title: Transfus. Clin. Biol. doi: 10.1016/j.tracli.2020.08.009 – volume: 10 start-page: 404 year: 2020 ident: ref_25 article-title: Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan publication-title: Front. Cell. Infect. Microbiol. doi: 10.3389/fcimb.2020.00404 – volume: 323 start-page: 1061 year: 2020 ident: ref_45 article-title: Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China publication-title: JAMA doi: 10.1001/jama.2020.1585 – volume: 382 start-page: 727 year: 2020 ident: ref_5 article-title: A novel coronavirus from patients with pneumonia in China, 2019 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2001017 – volume: 14 start-page: 3822 year: 2020 ident: ref_8 article-title: Diagnosing COVID-19: The Disease and Tools for Detection publication-title: ACS Nano doi: 10.1021/acsnano.0c02624 – volume: 21 start-page: 50 year: 2020 ident: ref_28 article-title: Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients publication-title: Egypt. J. Med. Hum. Genet. doi: 10.1186/s43042-020-00097-x – ident: ref_34 doi: 10.1101/2020.04.15.20063107 – volume: 395 start-page: 507 year: 2020 ident: ref_46 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study publication-title: Lancet doi: 10.1016/S0140-6736(20)30211-7 – volume: 26 start-page: 2267 year: 2020 ident: ref_3 article-title: Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2609.201932 – volume: 115 start-page: 4635 year: 2010 ident: ref_9 article-title: The relationship between blood groups and disease publication-title: Blood doi: 10.1182/blood-2010-01-261859 – volume: 105 start-page: 2706 year: 2020 ident: ref_17 article-title: COVID-19: Risk of infection is high, independently of ABO blood group publication-title: Haematologica doi: 10.3324/haematol.2020.266593 – volume: 18 start-page: 1085 year: 2008 ident: ref_37 article-title: Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies publication-title: Glycobiology doi: 10.1093/glycob/cwn093 – volume: 383 start-page: 1522 year: 2020 ident: ref_15 article-title: Genomewide Association Study of Severe Covid-19 with Respiratory Failure publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2020283 – volume: 53 start-page: 13 year: 2020 ident: ref_42 article-title: IL-6: Relevance for immunopathology of SARS-CoV-2 publication-title: Cytokine Growth Factor Rev. doi: 10.1016/j.cytogfr.2020.05.009 – ident: ref_39 doi: 10.1101/2020.01.31.929042 – ident: ref_22 doi: 10.22541/au.160349176.67670206/v1 – volume: 94 start-page: 127 year: 2020 ident: ref_40 article-title: Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus publication-title: J. Virol. doi: 10.1128/JVI.00127-20 – ident: ref_52 doi: 10.1101/2020.01.30.927806 – volume: 144 start-page: 110155 year: 2020 ident: ref_10 article-title: The influence of ABO blood groups on COVID-19 susceptibility and severity: A molecular hypothesis based on carbohydrate-carbohydrate interactions publication-title: Med. Hypotheses doi: 10.1016/j.mehy.2020.110155 – ident: ref_43 doi: 10.1111/vox.13004 – volume: 105 start-page: 2841 year: 2020 ident: ref_18 article-title: ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults publication-title: Haematologica doi: 10.3324/haematol.2020.265066 – ident: ref_13 doi: 10.1101/2020.03.11.20031096 – volume: 69 start-page: 1002 year: 2020 ident: ref_53 article-title: Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms publication-title: Gut doi: 10.1136/gutjnl-2020-320926 – volume: 426 start-page: 450 year: 2003 ident: ref_38 article-title: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus publication-title: Nature doi: 10.1038/nature02145 – volume: 395 start-page: 1054 year: 2020 ident: ref_6 article-title: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)30566-3 – ident: ref_49 doi: 10.1056/NEJMoa2002032 – volume: 26 start-page: 1586 year: 2020 ident: ref_4 article-title: Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020 publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2607.200885 – volume: 190 start-page: 24 year: 2020 ident: ref_24 article-title: Association between ABO blood groups and risk of SARS-CoV-2 pneumonia publication-title: Br. J. Haematol. doi: 10.1111/bjh.16797 – volume: 14 start-page: 564 year: 2020 ident: ref_47 article-title: Epidemiological, clinical, and virological characteristics of 465 hospitalized cases of coronavirus disease 2019 (COVID-19) from Zhejiang province in China publication-title: Influenza Other Respi. Viruses doi: 10.1111/irv.12758 – volume: 92 start-page: 589 year: 2020 ident: ref_51 article-title: Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection publication-title: J. Med. Virol. doi: 10.1002/jmv.25725 – ident: ref_19 doi: 10.1101/2020.06.13.20130211 – volume: 395 start-page: 497 year: 2020 ident: ref_48 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet doi: 10.1016/S0140-6736(20)30183-5 |
SSID | ssj0038469 |
Score | 2.361751 |
Snippet | Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm... Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between... Background and Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 276 |
SubjectTerms | Age groups Arabs Blood Grouping and Crossmatching Blood groups Coronaviruses COVID-19 COVID-19 - blood COVID-19 - ethnology Cross-Sectional Studies Disease Susceptibility - blood Disease transmission Fever Gender Glycoproteins Humans Infections Medical research Morphology Oxygen - blood Oxygen saturation Pandemics Questionnaires Retrospective Studies Severe acute respiratory syndrome coronavirus 2 Social networks Statistical analysis Surveys and Questionnaires Viral infections Viruses |
SummonAdditionalLinks | – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9QwELWgXJAQonwulGqQkDhZXcdex-GCttsuLQcqAa16i2zHUYtWSelmD_0h_F9m7GTpguBsJ3E8nnnj8fgNY2-t00U9sYZPnFBcaVWgznnJDeqSl86Pfcq2-KyPTtWn88l5H3Bb9mmVg02MhrpqPcXI9zKV05mOEsWHqx-cqkbR6WpfQuMuuycQaWidm_nHwRJLxFZyfwViEEckzBNpo8Rt_t7l94D_IQxRqhHfyG1Q-svT_DNh8hYCzR-xh73rCNMk6212JzSP2YMUd4N0negJ-4lyh-N49RHaGqb7J7BPuekQg0yIU9A2MDs5Oz7gooCz1YJYp2OC7A3YpgKKlrWrJRnA9zCFL6G7bofbmDCj0fOvMXuLhjJLee6LgM8RTS3E0kWAPiWO0jrob590N0_Z6fzw2-yI96UXuFfCdFzUYVyYSuQaMVxLqwM6OlmtvVZeZl7UNU6Gt94ZVTlZo9JLm2tlqlw7XalCPmNbTduEFwxMQCPivVMisyoIYzPiLLMGPYtgVRVGjA9zX_qel5zKYyxK3J-QrMpNWY3Yu3X_q8TI8c-eO4Moy14zl-XvdTRib9bNqFN0UGKbgFOc-khEbnzF8yT59aekVLQJHY9YvrEm1h2Ir3uzpbm8iLzdeV5M0Gd4-f9hvWL3M8qbiWGeHbbVXa_Ca3R8OrcbV_cvmOgEng priority: 102 providerName: ProQuest |
Title | The Impact of ABO Blood Grouping on COVID-19 Vulnerability and Seriousness: A Retrospective Cross-Sectional Controlled Study among the Arab Community |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33401440 https://www.proquest.com/docview/2475516419 https://www.proquest.com/docview/2475531286 https://pubmed.ncbi.nlm.nih.gov/PMC7795413 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1fb9MwELfYJqFJCPF3FEZ1SEg8BerYtR0khNqwsiGxoUGnvkWO44ihKtm6VKIfhO_LXZIGCttLXnx2Tr473519_pmxlzZVUT60JhimXAZSyQhtzonAoC05kbqBa6otjtXhVH6aDWd_6p_aCby6NrWj96Smi_nrn5er92jw7yjjxJT9zfkPjzxxQ_BoWm2xHfRKihKxz7I7URDoZ6MGtPGaPrvsthCSkovBpn_6L-j8t3byL2c0ucfutlEkjBqx32e3fPGA3Wm24KC5WfSQ_UIVgKP6FiSUOYzGJzCmMnWo95vQZUFZQHxydvQh4BGcLecEQF3Xyq7AFhnQxlm5vKK18C2M4NRXi3J9MRNi4j74WhdyEStxU_I-99iPEGuhfsUIMLxELm0K7UWUavWITScH3-LDoH2FIXCSmyrguR9EJuNaoTtXwiqPMU-YK6ekE6HjeY6T4axLjcxSkaP9C6uVNJlWqcpkJB6z7aIs_BMGxuN64lwqeWil58aGBF9mDQYZ3srM91iwnvvEtRDl9FLGPMFUhcSWbIqtx1519BcNOMeNlPtrUSZrHUtCqemYUPKox150zWhedGZiC49T3NAIdOI4xF4j-e5Xa5XpMb2hEx0BQXdvthTn32sIb62jIYYPT28c8xnbDal6pt7s2Wfb1WLpn2P4U6V9tqVnGr8m5vSdfOyznfHB8ZfTfq3xvwGrHAoo |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELem8QASQnzTMeCQQDxZq2PXcZAQ6jqmlo1Ngm3qW-Y4jhiqkm1NhfqH8G_wN3KXL1YQvO3ZTuL4Pn2--x1jr2yio2xgDR8kQnGlVYQy5yQ3KEtOJq7v6myLAz0-Vh-ng-ka-9nWwlBaZasTK0WdFo5i5FuBCulOR4no_fkFp65RdLvattCo2WLPL7_jkW3-brKD9H0dBLsfjkZj3nQV4E4JU3KR-X5kUhFqNE9aWu3RhgeZdlo5GTiRZT7F33KJUWkiM-RnaUOtTBrqRKeKwJdQ5d9QFBlH-Qmn3QFPoi0nd1ugzeNoecMaJFLKqL919s3jvglDEG6Eb3LVCP7l2f6ZoHnF4u3eZXcaVxWGNW_dY2s-v89u13E-qMuXHrAfyGcwqUotochguH0I25QLD1VQC-0iFDmMDk8mO1xEcLKYEcp1lZC7BJunQNG5YjEnhfsWhvDZl5dFW_0JI1o9_1Jli9FSRnVe_czjcwSLC1WrJEAfFldpE2iqXcrlQ3Z8LUR5xNbzIvdPGBiPSsu5RInAKi-MDQgjzRr0ZLxVqe8x3u597BocdGrHMYvxPES0ildp1WNvuvnnNQLIP2dutqSMG00wj3_zbY-97IZRhulixuYet7ieI9FTwFc8rinffUpKRYfefo-FKzzRTSB88NWR_OxrhRMehtEAfZSN_y_rBbs5Pvq0H-9PDvaeslsB5exUIaZNtl5eLvwzdLrK5HnF6cBOr1u0fgGXuEGx |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELemISEkhPhPYYCRQDxZrWPXdpAQ6lqqlaENAZv6ljmOI4aqZKypUD8IX4ZPx12chBUEb3u2kzi-vz7f_Y6Q5zZVcT60hg1TLplUMgaZc4IZkCUnUjdwIdviQO0dyXfz4XyL_GxrYTCtstWJtaLOSocx8n4kNd7pSB738yYt4sNk-ubsG8MOUnjT2rbTCCyy79ff4fi2fD2bAK1fRNH07efxHms6DDAnuakYz_0gNhnXCkyVElZ5sOdRrpySTkSO57nP4BddamSWihx4W1itpMm0SlUmEYgJ1P8VLcCrAlnS8-6wJ8Cuo-vNwf4xsMI6AEYKEQ_6p1897CE3COeGWCcXDeJfXu6fyZoXrN_0JrnRuK10FPjsFtnyxW1yPcT8aChlukN-AM_RWV12ScucjnYP6S7mxdM6wAU2kpYFHR8ezyaMx_R4tUDE6zo5d01tkVGM1JWrJSrfV3REP_rqvGwrQekYV88-1ZljuJRxyLFfeHgOIXJp3TaJgj8Lq7QpbSpfqvVdcnQpRLlHtouy8A8INR4UmHOp5JGVnhsbIV6aNeDVeCsz3yOs3fvENZjo2JpjkcDZCGmVbNKqR152888CGsg_Z-60pEwarbBMfvNwjzzrhkGe8ZLGFh62OMwR4DXAK-4HynefEkLiAXjQI3qDJ7oJiBW-OVKcfqkxw7WOh-CvPPz_sp6SqyBUyfvZwf4jci3C9J062rRDtqvzlX8M_leVPqkZnZKTy5asX3vRRfA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Impact+of+ABO+Blood+Grouping+on+COVID-19+Vulnerability+and+Seriousness%3A+A+Retrospective+Cross-Sectional+Controlled+Study+among+the+Arab+Community&rft.jtitle=International+journal+of+environmental+research+and+public+health&rft.au=El-Shitany%2C+Nagla+A&rft.au=El-Hamamsy%2C+Manal&rft.au=Alahmadi%2C+Ahlam+A&rft.au=Eid%2C+Basma+G&rft.date=2021-01-01&rft.eissn=1660-4601&rft.volume=18&rft.issue=1&rft_id=info:doi/10.3390%2Fijerph18010276&rft_id=info%3Apmid%2F33401440&rft.externalDocID=33401440 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1660-4601&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1660-4601&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1660-4601&client=summon |